Sarcoma: Cardiovascular and Oncologic Considerations: JACC: CardioOncology State-of-the-Art Review [0.03%]
心脏黏液瘤：心血管和肿瘤方面的影响：JACC心肿瘤学进展回顾
Daniel S Lefler,Elise F Nassif Haddad,Anju Nohria et al.
Daniel S Lefler et al.
Sarcomas are a heterogeneous group of connective tissue tumors that can occur at any anatomical site. This includes the heart and great vessels, where angiosarcoma, leiomyosarcoma, intimal sarcoma, and undifferentiated sarcomas are the domi...
Cardiovascular Surveillance in BRAF/MEK Inhibitor Therapy: Early Lessons from Prospective Data [0.03%]
BRAF/MEK抑制剂治疗中的心血管监测：前瞻性数据分析的早期启示
Viraj Shah,Tarek Nahle,Avirup Guha
Viraj Shah
Acute Myeloid Leukemia Drives Atrial Fibrillation Through TNFα Signaling Activation [0.03%]
急性髓系白血病通过TNFα信号激活驱动房颤
Ninad Oak,Jose Alberto Navarro-Garcia,Minhua Li et al.
Ninad Oak et al.
Behaviorally Designed Gamification and Physical Activity Among Breast and Prostate Cancer Survivors [0.03%]
行为学视角下的游戏化与乳腺癌和前列腺癌幸存者的身体活动
Alexander C Fanaroff,Jennifer A Orr,Chinyere Anucha et al.
Alexander C Fanaroff et al.
Background: Black and Hispanic cancer survivors exposed to cardiotoxic therapies are at higher risk for cardiovascular events than non-Hispanic White survivors, attributed to greater cardiovascular risk factors and lower ...
The FLC Ratio Reframed: Averting Unnecessary Heart Biopsies in Wild-Type ATTR Amyloidosis [0.03%]
ATTR野生型淀粉样变性中避免不必要的心脏活检的FLC比率新视角
Eli Muchtar,Mathew S Maurer
Eli Muchtar
Troponin Surveillance in Patients Receiving Immune Checkpoint Inhibitors [0.03%]
接受免疫检查点抑制剂的患者的心肌酶谱监测
Keila C Ostos-Mendoza,Jennifer L McQuade,Nicolas L Palaskas
Keila C Ostos-Mendoza
Prospective Evaluation of the Cardiovascular Effects of BRAF and MEK Inhibitors in Patients With Melanoma [0.03%]
评估braf和mek抑制剂对黑色素瘤患者心血管影响的前瞻性研究
Claire Glen,Stephen J H Dobbin,Kenneth Mangion et al.
Claire Glen et al.
Background: Rapidly accelerated fibrosarcoma B-type (BRAF) and MEK inhibitors have revolutionized outcomes for patients with BRAF-mutated melanoma. However, they are associated with cardiovascular adverse effects. The rea...
Inhibition, But Not Depletion, of Erk Signaling Ameliorates Anthracycline-Induced Cardiotoxicity in Zebrafish [0.03%]
抑制而非衰竭ERK信号通路可改善斑马鱼蒽环类药物引起的心脏毒性
Maryam Moossavi,Ping Zhu,Yonghe Ding et al.
Maryam Moossavi et al.
Background: Anthracycline-induced cardiotoxicity (AIC) is a unique type of cardiomyopathy that limits the clinical use of anthracyclines in cancer therapy. Although several cardiomyopathy-related pathways have been identi...
Reply: Blunted Exercise Response in Cancer Survivors: A Consequence of the Heart or Peripheral Muscle? [0.03%]
癌症幸存者运动反应减弱：是心脏还是外周肌肉的问题？
Tormod S Nilsen,Sara Hassing Johansen
Tormod S Nilsen